Education
About Us
Working with TipRanks
Follow Us
Collegium Pharmaceutical (COLL)
NASDAQ:COLL
Total Valuation
Collegium Pharmaceutical has a market cap or net worth of $1.32B. The enterprise value is $1.90B.
Market Cap$1.32B
Enterprise Value$1.90B
Share Statistics
Collegium Pharmaceutical has 31,753,210 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding31,753,210
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Collegium Pharmaceutical’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 9.78%.
Return on Equity (ROE)0.21
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)9.78%
Return on Capital Employed (ROCE)0.15
Revenue Per Employee2.19M
Profits Per Employee176.11K
Employee Count357
Asset Turnover0.47
Inventory Turnover7.76
Valuation Ratios
The current PE Ratio of Collegium Pharmaceutical is 24.3. Collegium Pharmaceutical’s PEG ratio is -3.12.
PE Ratio24.3
PS Ratio1.88
PB Ratio4.87
Price to Fair Value4.87
Price to FCF4.48
Price to Operating Cash Flow4.01
PEG Ratio-3.12
Income Statement
In the last 12 months, Collegium Pharmaceutical had revenue of 780.57M and earned 62.87M in profits. Earnings per share was 1.98.
Revenue780.57M
Gross Profit463.26M
Operating Income179.64M
Pretax Income92.62M
Net Income62.87M
EBITDA395.75M
Earnings Per Share (EPS)1.98
Cash Flow
In the last 12 months, operating cash flow was 329.32M and capital expenditures -1.74M, giving a free cash flow of 327.58M billion.
Operating Cash Flow329.32M
Free Cash Flow327.58M
Free Cash Flow per Share10.32
Dividends & Yields
Collegium Pharmaceutical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.34
52-Week Price Change46.52%
50-Day Moving Average46.67
200-Day Moving Average38.38
Relative Strength Index (RSI)31.85
Average Volume (3m)377.91K
Important Dates
Collegium Pharmaceutical upcoming earnings date is May 7, 2026, TBA (Confirmed).
Last Earnings DateFeb 26, 2026
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
Collegium Pharmaceutical as a current ratio of 1.57, with Debt / Equity ratio of 270.11%
Current Ratio1.57
Quick Ratio1.48
Debt to Market Cap0.56
Net Debt to EBITDA1.47
Interest Coverage Ratio2.18
Taxes
In the past 12 months, Collegium Pharmaceutical has paid 29.75M in taxes.
Income Tax29.75M
Effective Tax Rate0.32
Enterprise Valuation
Collegium Pharmaceutical EV to EBITDA ratio is 5.18, with an EV/FCF ratio of 6.26.
EV to Sales2.63
EV to EBITDA5.18
EV to Free Cash Flow6.26
EV to Operating Cash Flow6.23
Balance Sheet
Collegium Pharmaceutical has $406.53M in cash and marketable securities with $940.56M in debt, giving a net cash position of -$534.03M billion.
Cash & Marketable Securities$406.53M
Total Debt$940.56M
Net Cash-$534.03M
Net Cash Per Share-$16.82
Tangible Book Value Per Share-$16.20
Margins
Gross margin is 59.35%, with operating margin of 23.01%, and net profit margin of 8.05%.
Gross Margin59.35%
Operating Margin23.01%
Pretax Margin11.87%
Net Profit Margin8.05%
EBITDA Margin50.70%
EBIT Margin22.41%
Analyst Forecast
The average price target for Collegium Pharmaceutical is $57.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$57.00
Price Target Upside36.79% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast26.34%
EPS Growth Forecast-32.79%